A systematic review on the cost effectiveness of pharmacogenomics in developing countries: implementation challenges
{{output}}
The major challenges that delay the implementation of pharmacogenomics based clinical practice in the developing countries, primarily the low- and middle-income countries need to be recognized. This review was conducted to systematically review evidence of the... ...
